Literature DB >> 19772932

Microstructure and magnetic susceptibility of as-cast Zr-Mo alloys.

Naoyuki Nomura, Kei Oya, Yuko Tanaka, Ryota Kondo, Hisashi Doi, Yusuke Tsutsumi, Takao Hanawa.   

Abstract

The microstructures and magnetic susceptibilities of Zr-Mo alloys were investigated to develop a Zr alloy with a low magnetic susceptibility for magnetic resonance imaging (MRI). The microstructure was evaluated with an X-ray diffractometer (XRD), an optical microscope (OM) and a transmission electron microscope (TEM), and the magnetic susceptibility was measured with a magnetic susceptibility balance. The alpha' phase with acicular structure was dominant in Zr-1Mo alloys, while the omega and beta phases with the equiaxed and relatively flat (no acicular) microstructure was dominant in Zr-3Mo. The mixed microstructural features of Zr-1Mo and Zr-3Mo were observed in Zr-2Mo, which consists of the alpha', omega and beta phases. The beta phase is stabilized when the Mo content exceeds over 3 mass% Mo. As-cast Zr-Mo alloys showed a minimum value of magnetic susceptibility at 3 mass% Mo, and the value abruptly increased up to 10% Mo before remaining stable up to 15 mass% Mo. XRD, OM and TEM revealed that the minimum value of the susceptibility was closely related to the appearance of the athermal omega phase in the beta phase. As the Mo content decreases from 3 mass%, the alpha' phase appears with the omega and beta phases. On the other hand, as the Mo content increases from 3 mass%, the beta phase increases and the omega phase decreases. Thus the appearance of the alpha' and beta phase leads to an increase in magnetic susceptibility. The magnetic susceptibility of as-cast Zr-3Mo alloy was almost one-third that of Ti-6Al-4V, which is commonly used for medical implant devices. Zr-Mo alloys are useful for medical devices used under MRI. Copyright 2009 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.

Mesh:

Substances:

Year:  2009        PMID: 19772932     DOI: 10.1016/j.actbio.2009.09.013

Source DB:  PubMed          Journal:  Acta Biomater        ISSN: 1742-7061            Impact factor:   8.947


  8 in total

Review 1.  Research and development of metals for medical devices based on clinical needs.

Authors:  Takao Hanawa
Journal:  Sci Technol Adv Mater       Date:  2012-12-13       Impact factor: 8.090

2.  Influence of albumin on the electrochemical behaviour of Zr in phosphate buffered saline solutions.

Authors:  Lu-Ning Wang; Xian-Qiu Huang; Alyssa Shinbine; Jing-Li Luo
Journal:  J Mater Sci Mater Med       Date:  2012-11-21       Impact factor: 3.896

3.  Novel α + β Zr Alloys with Enhanced Strength.

Authors:  Anna Veverková; Dalibor Preisler; Mariia Zimina; Tereza Košutová; Petr Harcuba; Miloš Janeček; Josef Stráský
Journal:  Materials (Basel)       Date:  2021-01-15       Impact factor: 3.623

Review 4.  Advancing dental implants: Bioactive and therapeutic modifications of zirconia.

Authors:  Divya Chopra; Anjana Jayasree; Tianqi Guo; Karan Gulati; Sašo Ivanovski
Journal:  Bioact Mater       Date:  2021-11-05

5.  Migration of solidification grain boundaries and prediction.

Authors:  Hongmei Liu; Shenglu Lu; Yingbo Zhang; Hui Chen; Yungui Chen; Ma Qian
Journal:  Nat Commun       Date:  2022-10-07       Impact factor: 17.694

6.  Compressive Mechanical Properties and Shock-Induced Reaction Behavior of Zr/PTFE and Ti/PTFE Reactive Materials.

Authors:  Zhenwei Zhang; Yong He; Yuan He; Lei Guo; Chao Ge; Haifu Wang; Yue Ma; Hongyin Gao; Weixi Tian; Chuanting Wang
Journal:  Materials (Basel)       Date:  2022-09-20       Impact factor: 3.748

7.  Design and development of novel MRI compatible zirconium- ruthenium alloys with ultralow magnetic susceptibility.

Authors:  H F Li; F Y Zhou; L Li; Y F Zheng
Journal:  Sci Rep       Date:  2016-04-19       Impact factor: 4.379

8.  Athermal ω Phase and Lattice Modulation in Binary Zr-Nb Alloys.

Authors:  Mitsuharu Todai; Keisuke Fukunaga; Takayoshi Nakano
Journal:  Materials (Basel)       Date:  2022-03-21       Impact factor: 3.623

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.